<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4B8017E5-40E0-4ED8-9216-7010746F9003"><gtr:id>4B8017E5-40E0-4ED8-9216-7010746F9003</gtr:id><gtr:name>Institute of Cancer Research UK</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C80FA399-9F25-4473-8481-C60F0F3D5D18"><gtr:id>C80FA399-9F25-4473-8481-C60F0F3D5D18</gtr:id><gtr:name>Cancer Research UK Cambridge Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:department>Warwick Systems Biology Centre</gtr:department><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4B8017E5-40E0-4ED8-9216-7010746F9003"><gtr:id>4B8017E5-40E0-4ED8-9216-7010746F9003</gtr:id><gtr:name>Institute of Cancer Research UK</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C80FA399-9F25-4473-8481-C60F0F3D5D18"><gtr:id>C80FA399-9F25-4473-8481-C60F0F3D5D18</gtr:id><gtr:name>Cancer Research UK Cambridge Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A6639F33-85DB-4CA2-93D6-3700CA6A03D2"><gtr:id>A6639F33-85DB-4CA2-93D6-3700CA6A03D2</gtr:id><gtr:firstName>Richard Stephen</gtr:firstName><gtr:surname>Savage</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0902104"><gtr:id>B37C192F-939C-4463-A43A-2B749AAEEE01</gtr:id><gtr:title>Applications of probabilistic machine learning to medical biostatistics</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0902104</gtr:grantReference><gtr:abstractText>Medical research generates huge amounts of scientific data. My research creates new ways to extract the important scientific knowledge from these large, complex data-sets. I do this using Bayesian statistics, which are a particularly powerful set of techniques which combine all available information to produce the best possible results, and which can handle the rich, complicated structure that these data often contain. This can be regarded as a kind of artificial intelligence that makes sense of much bigger data-sets than the human brain could process or organise.

This approach opens up the possibility of systems medicine, modelling whole biological systems at once to gain better understanding of their function. This is becoming a hugely important area of science, but requires just the sort of statistical tools I?ll be developing with this research.

The area of medicine I work on is cancer, particularly focusing on breast cancer, myeloma, ovarian carcinogenesis and basal cell carcinoma. I work with collaborators in medicine, who have large data-sets that cannot currently be analysed in the way I propose. By applying Bayesian methods of analysis I will be working with them to understand better the medical implications of their data, and move towards improved clinical outcomes.</gtr:abstractText><gtr:technicalSummary>Biomedical research accumulates huge volumes of scientific data. Because of this, it is necessary to develop computational and statistical methods that can effectively extract important information from these data. These data-sets can present a number of challenges. The underlying biological systems are often highly complex, leading to rich structure in the data. They are typically also noisy, both as the result of measurement imprecision and also any biological variation that may be intrinsic to the system studied. The data-sets are often also large, particularly from high-throughput technologies such as microarrays that allow simultaneous measurement of whole genomes.

This work will develop novel non-parametric Bayesian methods to address key questions in three areas of medical biostatistics. Firstly, the integration of multiple sources of data into combined biomarker discovery/outcome prediction models. Secondly, the use of Bayesian model averaging techniques to develop more effective data models for clustering of gene expression data. Thirdly, the creation of hierarchical data models that can simultaneously cluster, identify biomarkers and make outcome predictions.

Non-parametric Bayesian methods represent a powerful way to address these challenges. Because they are highly flexible, they can accurately model the sort of complex structure often found in biomedical data-sets and can select in a principled way the most appropriate model structure, leading directly to superior data modelling results. Their Bayesian nature also makes them suitable for modelling uncertainty in the data and for using all available sources of information for a given analysis. The particular families of non-parametric models I?ll be using are Gaussian Process and Dirichlet Process models, both of which are on the cutting-edge of current machine learning research.

The medical focus of this work will be cancer, with a particular early focus on data-sets investigating breast canc, myeloma, ovarian carcinogenesis and basal cell carcinoma. My collaborators and I will extend this work both as new data-sets become available, and also as we identify promising analysis results to follow up, for example in the design of new experiments or clinical trials. 

This work will produce original research in probabilistic machine learning and I will develop these innovations into robust software tools so that the broader scientific community can benefit fully from this work.</gtr:technicalSummary><gtr:fund><gtr:end>2014-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>351627</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Warwick</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Warwick Medical School</gtr:department><gtr:description>Early Cancer Detection Consortium</gtr:description><gtr:id>66A69138-73E8-4383-BF89-9696FC655640</gtr:id><gtr:impact>CRUK funding
Systematic review
Health economic modelling
Delphi exercise</gtr:impact><gtr:outcomeId>546360a931bc04.98285845-1</gtr:outcomeId><gtr:partnerContribution>Numerous other aspects of the project</gtr:partnerContribution><gtr:piContribution>I am leading the machine learning efforts</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Institute of Cancer Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>ICR, London</gtr:description><gtr:id>49F30E97-F018-4681-B8CE-0116B6910302</gtr:id><gtr:impact>Still in early stages. First paper currently in prep.</gtr:impact><gtr:outcomeId>LwdKKMsWYUE-1</gtr:outcomeId><gtr:partnerContribution>Provision and processing of the breast cancer data. Full participation in the scientific analysis of the results.</gtr:partnerContribution><gtr:piContribution>Development of machine learning methods to predict clinical outcomes in breast cancer, combining molecular and imaging data. Full participation in the scientific analysis of the results.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Engineering</gtr:department><gtr:description>Machine learning, Cambridge</gtr:description><gtr:id>6C11EB3D-1D22-4271-9B50-9EB8C9CC4E75</gtr:id><gtr:impact>3 papers have been published.
The collaboration is multi-disciplinary, covering machine learning, computer science, statistics, bioinformatics, systems biology and medicine</gtr:impact><gtr:outcomeId>Jv81ZasRtNK-1</gtr:outcomeId><gtr:partnerContribution>Development of machine learning models.</gtr:partnerContribution><gtr:piContribution>Development of machine learning models and their application to various biomedical problems.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK Cambridge Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CRI, Cambridge</gtr:description><gtr:id>ACF46B0B-26D1-4FDF-9788-6E04A9EB2C6E</gtr:id><gtr:impact>'Patient-specific data fusion defines prognostic cancer subtypes', Yuan Y., Savage R. (joint first-author with YY) and Markowetz F., 2011, PLoS Computational Biology 7(10)</gtr:impact><gtr:outcomeId>FwGogTcVCse-1</gtr:outcomeId><gtr:partnerContribution>Cutting edge genomic cancer data and scientific knowledge.</gtr:partnerContribution><gtr:piContribution>Nonparametric Bayesian algorithms and scientific knowledge.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>319109</gtr:amountPounds><gtr:country>Qatar, State of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Qatar National Research Fund</gtr:department><gtr:description>Qatar National Research Fund</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>Qatar Foundation</gtr:fundingOrg><gtr:id>0C9D525D-69ED-4E1F-801B-E1C19B9DF61C</gtr:id><gtr:outcomeId>CeCQQefEduu</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-12-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A fast, Bayesian clustering tool. The version of this method for clustering gene expression timeseries was developed partly under the aegis of this fellowship. This tool publicly available for download from the Bioconductor project:
http://www.bioconductor.org/packages/release/bioc/html/BHC.html?pagewanted=all</gtr:description><gtr:id>A0BFA3AE-3A55-4ECC-A6FC-1AF07E93950E</gtr:id><gtr:impact>Since it's release, the BHC package has been downloaded 1429 times from the Bioconductor website.</gtr:impact><gtr:outcomeId>Cq9hzfmHNS5</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>BHC</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:url>http://www.bioconductor.org/packages/release/bioc/html/BHC.html?pagewanted=all</gtr:url><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Patient-Specific Data Fusion (PSDF). A nonparametric Bayesian method for identifying cancer subtypes using gene expression and copy-number data. We have provided a publicly-available software implementation of this method, which can be downloaded from the web.</gtr:description><gtr:id>ECCE89EA-C08B-491A-B238-D9D9A518A507</gtr:id><gtr:impact>We have identified a new subtype of prostate cancer with extremely poor prognosis. This result was recently published in PLoS Computational Biology and we are currently working to follow up this result.</gtr:impact><gtr:outcomeId>KsMRqFDQud6</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>PSDF</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>46D6DB50-7681-47D1-92E2-CD3CA8E072B9</gtr:id><gtr:title>Bayesian correlated clustering to integrate multiple datasets.</gtr:title><gtr:parentPublicationTitle>Bioinformatics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6366af30f48ed0c38de612947989a860"><gtr:id>6366af30f48ed0c38de612947989a860</gtr:id><gtr:otherNames>Kirk P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1367-4803</gtr:issn><gtr:outcomeId>pm_12797_27_23047558</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9AA1300-3D91-42A5-B5D8-6F93DC6C91C9</gtr:id><gtr:title>Differentiating coeliac disease from irritable bowel syndrome by urinary volatile organic compound analysis--a pilot study.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e6cff4c01a1af272226e7837713cc74"><gtr:id>7e6cff4c01a1af272226e7837713cc74</gtr:id><gtr:otherNames>Arasaradnam RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>54635eb9628905.49492906</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7820496-1C47-4C17-85AD-3EE00A00CFE3</gtr:id><gtr:title>Bayesian hierarchical clustering for microarray time series data with replicates and outlier measurements.</gtr:title><gtr:parentPublicationTitle>BMC bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/365e1b1bc29fb6c75c3410c902c75711"><gtr:id>365e1b1bc29fb6c75c3410c902c75711</gtr:id><gtr:otherNames>Cooke EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-2105</gtr:issn><gtr:outcomeId>Bi7Q2Ms41PG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54C96317-E42D-4E31-8E1A-77F611AC6B11</gtr:id><gtr:title>Rapid, accurate, and on-site detection of C. difficile in stool samples.</gtr:title><gtr:parentPublicationTitle>The American journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17d617752a59164629ab291f48412060"><gtr:id>17d617752a59164629ab291f48412060</gtr:id><gtr:otherNames>Bomers MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9270</gtr:issn><gtr:outcomeId>56b328981457e5.41545285</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D48BAC59-5BF1-4A06-A32E-9271D54AB869</gtr:id><gtr:title>Prediction of resistance to chemotherapy in ovarian cancer: a systematic review.</gtr:title><gtr:parentPublicationTitle>BMC cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35c63c5f76605a2c103f2d61710a47d4"><gtr:id>35c63c5f76605a2c103f2d61710a47d4</gtr:id><gtr:otherNames>Lloyd KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2407</gtr:issn><gtr:outcomeId>56b32897b05031.82199071</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97BDA09B-23DB-40D6-A4D4-8BE3F5257AC3</gtr:id><gtr:title>The application of FAIMS gas analysis in medical diagnostics.</gtr:title><gtr:parentPublicationTitle>The Analyst</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95085a26a1259b33ab8d5b67e6a91609"><gtr:id>95085a26a1259b33ab8d5b67e6a91609</gtr:id><gtr:otherNames>Covington JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0003-2654</gtr:issn><gtr:outcomeId>56b32898422da8.39180949</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B07B0C7-C630-4B60-8560-B5CA973AC4FD</gtr:id><gtr:title>Prediction of human population responses to toxic compounds by a collaborative competition.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7fb522d71f3e9cd11b260c5b682f27ca"><gtr:id>7fb522d71f3e9cd11b260c5b682f27ca</gtr:id><gtr:otherNames>Eduati F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>56b3289873bcc8.87263602</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>825948C9-2153-4956-81D2-CB3E7A7409F5</gtr:id><gtr:title>Bayesian modeling suggests that IL-12 (p40), IL-13 and MCP-1 drive murine cytokine networks in vivo.</gtr:title><gtr:parentPublicationTitle>BMC systems biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1cf2beaa15f7bd54bc4f4e8330a042d3"><gtr:id>1cf2beaa15f7bd54bc4f4e8330a042d3</gtr:id><gtr:otherNames>Field SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1752-0509</gtr:issn><gtr:outcomeId>56b32898b2fce7.43269604</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CC0D998-F1CA-4FF3-BAE4-E4DAD5CC664E</gtr:id><gtr:title>Biomarkers of early stage osteoarthritis, rheumatoid arthritis and musculoskeletal health.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35a40d9eb91032355136d85de0a91f5e"><gtr:id>35a40d9eb91032355136d85de0a91f5e</gtr:id><gtr:otherNames>Ahmed U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56b32897df07e0.66285267</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6447B545-7725-4F0D-BBB3-1162C68F96B9</gtr:id><gtr:title>Patient-specific data fusion defines prognostic cancer subtypes.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16596fd19894c1f0a522ab6785355ba1"><gtr:id>16596fd19894c1f0a522ab6785355ba1</gtr:id><gtr:otherNames>Yuan Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>aS4oS2G7yZN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25F02988-FF1D-4FF9-A514-D66221D0206A</gtr:id><gtr:title>Predicting chemoinsensitivity in breast cancer with 'omics/digital pathology data fusion.</gtr:title><gtr:parentPublicationTitle>Royal Society open science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf97f9e90cd7b55eb86658085f016f6d"><gtr:id>bf97f9e90cd7b55eb86658085f016f6d</gtr:id><gtr:otherNames>Savage RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2054-5703</gtr:issn><gtr:outcomeId>58b006edd13907.84342792</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>133E5423-1CDB-4B6F-A6CE-252765655CDC</gtr:id><gtr:title>Bayesian hierarchical clustering for studying cancer gene expression data with unknown statistics.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59a8eb25eb7024bb9329d076aba3f80e"><gtr:id>59a8eb25eb7024bb9329d076aba3f80e</gtr:id><gtr:otherNames>Sirinukunwattana K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>54635f324e3670.16539613</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4F9D7C1-DD50-4466-A3F8-B52AB7D85139</gtr:id><gtr:title>Accelerating Bayesian hierarchical clustering of time series data with a randomised algorithm.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0941a4c80e2f1c8823821bc469c52e6"><gtr:id>f0941a4c80e2f1c8823821bc469c52e6</gtr:id><gtr:otherNames>Darkins R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12797_27_23565168</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0902104</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>FB395309-E202-4FE8-87B0-041A3D72D4D4</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>2.5  Research design and methodologies (aetiology)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>90487A08-C473-4CEB-B6D9-011A74AD06CF</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>8.4  Research design and methodologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>